NCT01703793View on ClinicalTrials.gov

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Seborrheic Dermatitis

Interventions

DRUG

Test Product 49778

DRUG

Test Product 10156

DRUG

Vehicle (placebo)

Trial Locations (22)

Unknown

Fremont

Los Angeles

San Diego

New Haven

Aventura

Augusta

Snellville

Evansville

Detroit

Fridley

Paramus

Mount Kisco

New York

High Point

Portland

Philadelphia

Arlington

Austin

College Station

Plano

Webster

Salt Lake City

All Listed Sponsors

lead

Medicis Global Service Corporation

INDUSTRY

NCT01703793 - Safety and Efficacy Study in Subjects With Seborrheic Dermatitis | Biotech Hunter | Biotech Hunter